Rotterdam study. J Clin Endocrinol Metab 2002;
87:
3632.
7. Rhoden EL and Morgentaler A: Symptomatic
response rates to testosterone therapy and the
likelihood of completing 12 months of therapy in
clinical practice. J Sex Med 2010;
7:
277.
8. McCullough AR, Khera M, Goldstein I et al:
A multi-institutional observational study of
testosterone levels after testosterone pellet
(Testopel(
Ò
)) insertion. J Sex Med 2012;
9:
594.
9. Pastuszak AW, Mittakanti H, Liu JS et al:
Pharmacokinetic
evaluation
and
dosing
of
subcutaneous testosterone pellets. J Androl
2012;
33:
927.
10. Marbury T, Hamill E, Bachand R et al: Evaluation
of the pharmacokinetic profiles of the new
testosterone topical gel formulation, Testim,
compared to AndroGel. Biopharm Drug Dispos
2003;
24:
115.
11. Smith RP, Khanna A, Coward RM et al: Factors
influencing patient decisions to initiate and
discontinue subcutaneous testosterone pellets
(Testopel) for treatment of hypogonadism. J Sex
Med 2013;
10:
2326.
12. Heufelder AE, Saad F, Bunck MC et al: Fifty-
two-week treatment with diet and exercise plus
transdermal testosterone reverses the metabolic
syndrome and improves glycemic control in
men with newly diagnosed type 2 diabetes and
subnormal plasma testosterone. J Androl 2009;
30:
726.
13. Haider A, Gooren LJ, Padungtod P et al:
Improvement of the metabolic syndrome and
of non-alcoholic liver steatosis upon treatment
of hypogonadal elderly men with parenteral
testosterone undecanoate. Exp Clin Endocrinol
Diabetes 2010;
118:
167.
14. Morley J, Charlton E, Patrick P et al: Validation
of a screening questionnaire for androgen
deficiency in aging males. Metabolism 2000;
49:
1239.
15. Mohamed O, Freundlich R, Dakik H et al: The
quantitative ADAM questionnaire: a new tool
in quantifying the severity of hypogonadism. Int
J Impot Res 2010;
22:
20.
16. Yamaguchi K, Ishikawa T, Chiba K et al:
Assessment of possible effects for testosterone
replacement therapy in men with symptomatic
late-onset hypogonadism. Andrologia 2011;
43:
52.
17. Taylor F and Levine L: Clomiphene citrate and
testosterone gel replacement therapy for male
hypogonadism: efficacy and treatment cost.
J Sex Med 2010;
7:
269.
18. Shabsigh A, Kang Y, Shabsign R et al: Clomi-
phene citrate effects on testosterone/estrogen
ratio in male hypogonadism. J Sex Med 2005;
2:
716.
19. Whitten S, Nangia A and Kolettis P: Select
patients with hypogonadotropic hypogonadism
may respond to treatment with clomiphene
citrate. Fertil Steril 2006;
86:
1664.
20. Goldstein S, Siddhanti S, Ciaccia A et al: A
pharmacological review of selective oestrogen
receptor modulators. Hum Reprod Update 2000;
6:
212.
21. Willets A, Corbo J and Brown J: Clomiphene
for the treatment of male infertility. Reprod Sci
2013;
20:
739.
22. Moskovic DJ, Katz DJ, Akhavan A et al: Clomi-
phene citrate is safe and effective for long-term
management of hypogonadism. BJU Int 2012;
110:
1524.
23. Katz DJ, Nabulsi O, Tal R et al: Outcomes of
clomiphene citrate treatment in young hypo-
gonadal men. BJU Int 2012;
110:
573.
24. Ko EY, Siddiqi K, Brannigan RE et al: Empirical
medical therapy for idiopathic male infertility:
a survey of the American Urological Association.
J Urol 2012;
187:
973.
25. Yeap BB, Alfonso H, Chubb SA et al: In older men
an optimal plasma testosterone is associated
with reduced all-cause mortality and higher
dihydrotestosterone with reduced ischemic heart
disease mortality, while estradiol levels do not
predict mortality. J Clin Endocrinol Metab 2014;
99:
E9.
26. Finkelstein JS, Lee H, Burnett-Bowie SA et al:
Gonadal steroids and body composition, strength,
and sexual function in men. N Engl J Med 2013;
369:
1011.
27. Hajjar RR, Kaiser FE and Morley JE: Outcomes
of long-term testosterone replacement in older
hypogonadal males: a retrospective analysis.
J Clin Endocrinol Metab 1997;
82:
3793.
28. Harman SM, Metter EJ, Tobin JD et al:
Longitudinal effects of aging on serum total
and free testosterone levels in healthy men.
Baltimore Longitudinal Study of Aging. J Clin
Endocrinol Metab 2001;
86:
724.
TESTOSTERONE SUPPLEMENTATION VERSUS CLOMIPHENE CITRATE FOR HYPOGONADISM
879